Bristol-Myers Squibb Leads $237 Million Series E Financing Round for Pathos AI

MT newswire2026/10/23 13:39

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

09:39 AM EDT, 10/23/2026 (MT Newswires) -- Bristol-Myers Squibb (BMY) led a $237 million Series E financing round for Pathos AI, alongside participation from existing investors, the artificial intelligence drug development company said on Friday. Proceeds from the financing will be used to further scale Pathos AI's proprietary AI platform Foundry, and advance development of the company's portfolio, according to a statement.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Bristol-Myers Squibb Leads $237 Million Series E Financing Round for Pathos AI

You may also like

Crypto prices